MACS® GMP Recombinant Human IL-4

Interleukin 4 (IL-4) is an anti-inflammatory cytokine and is a key regulator in humoral and adaptive immunity. It has complex biological roles and promotes growth and differentiation of B cells and T cells, and cells of the monocytic lineage.

MACS GMP Recombinant Human IL-4 is designed for ex vivo cell culture processing. No animal- or human-derived materials were used for the manufacture of this product, unless otherwise stated in the respective Certificate of Origin. The product is lyophilized without carrier protein or preservatives.

Choose your product:

Related products for MACS® GMP Recombinant Human IL-4

Specifications for MACS® GMP Recombinant Human IL-4
Overview

Interleukin 4 (IL-4) is an anti-inflammatory cytokine and is a key regulator in humoral and adaptive immunity. It has complex biological roles and promotes growth and differentiation of B cells and T cells, and cells of the monocytic lineage.

MACS GMP Recombinant Human IL-4 is designed for ex vivo cell culture processing. No animal- or human-derived materials were used for the manufacture of this product, unless otherwise stated in the respective Certificate of Origin. The product is lyophilized without carrier protein or preservatives.

Detailed product information

Biological activity

Determination method
The specific activity is determined by proliferation assay according to Kitamura et al.1 using TF-1 cells provided by the German Resource Centre for Biological Material (DSMZ). The proliferation assay was calibrated with the international standard for human IL-4 (NIBSC code 88/656) provided by the National Institute for Biological Standards and Control.
Minimal specific activity
≥ 2×106 IU/mg
Typical specific activity
≥ 4.7×106 IU/mg
Background information

IL-4 is predominantly secreted by activated CD4+ memory and effector TH2 cells, basophils, and mast cells. It promotes the proliferation and differentiation of B cells, as well as immunoglobulin isotype switching, and MHC class II antigen and low-affinity IgE receptor expression. Furthermore, IL-4 induces the differentiation of naive CD4+ T cells into helper TH2 cells, while suppressing TH1 development, and promotes chemotaxis of mast cells and basophils.

Applications

MACS GMP Recombinant Human IL-4 can be used for a variety of applications, including the ex vivo generation of human dendritic cells from enriched CD14+ monocyte populations.2–4

Technical specifications

  • Identity/ Molecular mass: 15088 Da, determined by mass spectrometry. This corresponds to the mature form of human IL-4 including an N-terminal methionine (130 amino acids). Source E. coli.
  • Purity: ≥ 97 % as determined by chip electrophoresis.
  • Endotoxin content: < 50 EU/mg, as determined by kinetic Limulus Amoebocyte Lysate (LAL) assay (Pharmacopoeia Europaea (Ph. Eur.)).
  • Residual host cell DNA content: < 20 ng/mg, as determined by quantitative PCR specific for E. coli genomic DNA.
  • Residual host cell protein content: < 0.5 µg/mg, as determined by E. coli HCP ELISA.

The product quality certificate of our MACS® GMP Recombinant Human IL-4 was adapted. Learn more here

Quality statement

MACS GMP Products are manufactured and tested under a quality management system (ISO 13485) and are in compliance with relevant GMP guidelines. They are designed following the recommendations of USP <1043> on ancillary materials.

Disclaimer

MACS GMP Products are for ex vivo cell processing only, and are not intended for human in vivo applications. For regulatory status in the USA, please contact your local representative.

Product data and images for MACS® GMP Recombinant Human IL-4
Figure 1

The biological activity of MACS GMP Recombinant Human IL-4 was determined by proliferation assay using TF-1 cells.

Figure 2

Mass spectrometry analysis (ESI-MS) of MACS GMP Recombinant Human IL-4. The peak corresponds to the calculated molecular mass of 15088 Da.

Figure 3

MACS GMP Recombinant Human IL-4 batch-to-batch variability. Activity of three different production batches of Human MACS GMP IL-4.

Resources for MACS® GMP Recombinant Human IL-4
Citations for MACS® GMP Recombinant Human IL-4
Publications
  1. Kitamura, T. et al. (1991) IL-1 up-regulates the expression of cytokine receptors on a factor-dependent human hemopoetic cell line, TF-1. Int. Immunol. 3: 571-577
  2. Bender, A. et al. (1996) Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods 196: 121-135
  3. Romani, N. et al. (1996) Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods 196: 137-151
  4. Jonuleit, H. et al. (1997) Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27: 3135-3142

You have previously chosen International as your location.
What do you want to do?